Figure 2From: The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancerFrequency of Wilms tumor (WT) 1-specific cytotoxic T lymphocytes (CTLs) in patients before and after therapy. WT1-specific CTLs were detected using WT1 tetramers in 17 patients. Data are expressed as a percentage of peripheral blood mononuclear cells.Back to article page